Treatment with anti‐CC chemokine receptor 3 monoclonal antibody or dexamethasone inhibits the migration and differentiation of bone marrow CD34+ progenitor cells in an allergic mouse model

@article{Ben2008TreatmentWA,
  title={Treatment with anti‐CC chemokine receptor 3 monoclonal antibody or dexamethasone inhibits the migration and differentiation of bone marrow CD34+ progenitor cells in an allergic mouse model},
  author={S. Ben and X. Li and F. Xu and W. Xu and W. Li and Z. Wu and H. Huang and H. Shi and H. Shen},
  journal={Allergy},
  year={2008},
  volume={63}
}
  • S. Ben, X. Li, +6 authors H. Shen
  • Published 2008
  • Medicine
  • Allergy
  • Background:  The migration and in situ differentiation of CD34+ progenitors contribute to inflammatory eosinophilia in asthma and corticosteroids have been widely used in asthma. However, little is know about whether and how corticosteroids modulate the migration and differentiation of CD34+ progenitors. This study was aimed to investigate the impact of anti‐CC chemokine receptor 3 (CCR3) or dexamethasone on inflammatory eosinophilia in asthma and possible mechanism(s) underlying the action of… CONTINUE READING
    Exogenous interleukin-17A inhibits eosinophil differentiation and alleviates allergic airway inflammation.
    14
    Targeting eosinophil biology in asthma therapy.
    50

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 36 REFERENCES
    Regulation of Chemokine Receptor Expression in Eosinophils
    31